VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,711,058 | -12.7% | 137,906 | -2.3% | 0.52% | -8.2% |
| Q2 2023 | $4,251,721 | -11.4% | 141,206 | -4.8% | 0.57% | -18.8% |
| Q1 2023 | $4,800,555 | +12.1% | 148,394 | -0.7% | 0.70% | +4.3% |
| Q4 2022 | $4,283,000 | +22.0% | 149,456 | +2.6% | 0.68% | +16.6% |
| Q3 2022 | $3,512,000 | -8.8% | 145,606 | +3.5% | 0.58% | +16.5% |
| Q2 2022 | $3,851,000 | -31.7% | 140,656 | -4.4% | 0.50% | -39.8% |
| Q1 2022 | $5,640,000 | +20.7% | 147,060 | +0.8% | 0.83% | +25.0% |
| Q4 2021 | $4,673,000 | +12.4% | 145,892 | +3.4% | 0.66% | +3.4% |
| Q3 2021 | $4,158,000 | -13.5% | 141,089 | -0.3% | 0.64% | -17.8% |
| Q2 2021 | $4,808,000 | +4.7% | 141,489 | +0.1% | 0.78% | -5.0% |
| Q1 2021 | $4,594,000 | +0.8% | 141,339 | +11.7% | 0.82% | -12.2% |
| Q4 2020 | $4,556,000 | – | 126,489 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |